Latest stock market podcasts

Bell Direct

March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

From the helm: Brickworks' Lindsay Partridge

Bell Direct

February 12, 2020

Morning Bell 11 February

Bell Direct

February 10, 2020

Morning Bell 10 February

Bell Direct

February 9, 2020

Weekly Wrap 7 February

Bell Direct

February 7, 2020

Morning Bell 7 February

Bell Direct

February 6, 2020

Morning Bell 6 February

Bell Direct

February 5, 2020

From the helm: Banks/insurers, reporting season, Head of Bell Potter Research, TS Lim

Bell Direct

February 5, 2020

Morning Bell 5 February

Bell Direct

February 4, 2020

Reporting season: Temple & Webster results

Bell Direct

February 4, 2020

Morning Bell 4 February

Bell Direct

February 3, 2020

Morning Bell 3 February

Bell Direct

February 2, 2020

January Market Overview

Bell Direct

January 31, 2020